Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 127 Myeloid 94 Sarcoma 69 Gastrointestinal 54 Lymphoid 28 Thoracic 16 CNS 15 Genitourinary 11 Gynecologic 9 Dermatologic 9 Other solid neoplasm 7 Breast 7 Tumor-Agnostic 3 Plasma cell 3 Head & Neck 2 Other 1

Conditions

Mucositis 1 Leukemia 1

Interventions

Exercise 15 Metformin 14 Surveys and Questionnaires 12 Radiotherapy 9 Methods 7 naloxegol 6 Nutrition Assessment 6 Counseling 6 alvimopan 5 Resistance Training 5 Psychiatric Rehabilitation 5 Exenatide 5 Early Intervention, Educational 5 Diet Therapy 5 Diet 5 Sugars 4 Mindfulness-Based Stress Reduction 4 Injections 4 Fibroblast Growth Factor 7 4 Educational Status 4 Drug Therapy 4 Vitamin D 3 Therapeutics 3 Standard of Care 3 Liraglutide 3 Interviews as Topic 3 Fentanyl 3 Cryotherapy 3 Cognitive Behavioral Therapy 3 Cisplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Imatinib Mesylate × Other × Clear all

NCT01085617 2025-03-30

UKALL14

University College, London

OtherOther hematologic neoplasm

Leukemia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡